RYAN vs. EQH, ERIE, BRO, WTW, AJG, BEN, BAP, DOC, AMH, and HST
Should you be buying Ryan Specialty stock or one of its competitors? The main competitors of Ryan Specialty include Equitable (EQH), Erie Indemnity (ERIE), Brown & Brown (BRO), Willis Towers Watson Public (WTW), Arthur J. Gallagher & Co. (AJG), Franklin Resources (BEN), Credicorp (BAP), Healthpeak Properties (DOC), American Homes 4 Rent (AMH), and Host Hotels & Resorts (HST). These companies are all part of the "finance" sector.
Ryan Specialty (NYSE:RYAN) and Equitable (NYSE:EQH) are both large-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, community ranking, dividends and analyst recommendations.
Equitable received 232 more outperform votes than Ryan Specialty when rated by MarketBeat users. Likewise, 60.43% of users gave Equitable an outperform vote while only 38.33% of users gave Ryan Specialty an outperform vote.
Ryan Specialty has a net margin of 9.36% compared to Equitable's net margin of 0.00%. Ryan Specialty's return on equity of 44.84% beat Equitable's return on equity.
Ryan Specialty currently has a consensus target price of $54.25, indicating a potential upside of 8.05%. Equitable has a consensus target price of $39.67, indicating a potential upside of 6.89%. Given Ryan Specialty's higher probable upside, equities analysts clearly believe Ryan Specialty is more favorable than Equitable.
In the previous week, Equitable had 2 more articles in the media than Ryan Specialty. MarketBeat recorded 10 mentions for Equitable and 8 mentions for Ryan Specialty. Equitable's average media sentiment score of 1.16 beat Ryan Specialty's score of 0.35 indicating that Equitable is being referred to more favorably in the news media.
Ryan Specialty pays an annual dividend of $0.44 per share and has a dividend yield of 0.9%. Equitable pays an annual dividend of $0.88 per share and has a dividend yield of 2.4%. Ryan Specialty pays out 86.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Equitable pays out 26.0% of its earnings in the form of a dividend. Equitable is clearly the better dividend stock, given its higher yield and lower payout ratio.
84.8% of Ryan Specialty shares are owned by institutional investors. Comparatively, 92.7% of Equitable shares are owned by institutional investors. 11.1% of Ryan Specialty shares are owned by insiders. Comparatively, 1.0% of Equitable shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Equitable has higher revenue and earnings than Ryan Specialty. Equitable is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.
Ryan Specialty has a beta of 0.52, suggesting that its stock price is 48% less volatile than the S&P 500. Comparatively, Equitable has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500.
Summary
Equitable beats Ryan Specialty on 13 of the 20 factors compared between the two stocks.
Get Ryan Specialty News Delivered to You Automatically
Sign up to receive the latest news and ratings for RYAN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ryan Specialty Competitors List
Related Companies and Tools
